Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 1
1955 1
1960 1
1962 1
1967 1
1973 1
1974 2
1975 2
1976 2
1977 5
1978 6
1979 4
1980 5
1981 2
1982 7
1983 4
1984 1
1986 6
1987 2
1988 3
1989 5
1990 6
1991 6
1992 9
1993 2
1994 6
1995 6
1996 7
1997 7
1998 6
1999 5
2000 6
2001 5
2002 8
2003 9
2004 21
2005 61
2006 156
2007 182
2008 228
2009 254
2010 231
2011 269
2012 304
2013 314
2014 318
2015 298
2016 314
2017 315
2018 292
2019 305
2020 360
2021 381
2022 324
2023 309
2024 338
2025 373
2026 94

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,319 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J; International Task Force on Osteonecrosis of the Jaw. Khan AA, et al. J Bone Miner Res. 2015 Jan;30(1):3-23. doi: 10.1002/jbmr.2405. J Bone Miner Res. 2015. PMID: 25414052 Free article.
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ), and offers recommendations for its management based on multidisciplinar …
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagn …
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ. Anastasilakis AD, et al. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888. J Clin Endocrinol Metab. 2022. PMID: 34922381 Free PMC article. Review.
CONTEXT: Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and skeletal-related events (SREs) in patients with bone metastases (BM). Osteonecrosis of the jaw (ONJ) is a rare but severe condition manifested as necrotic bo …
CONTEXT: Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and skeletal-related events (SREs) …
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.
Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. Ruggiero SL, et al. J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21. J Oral Maxillofac Surg. 2022. PMID: 35300956 Review.
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ) - formerly referred to as bisphosphonate-related osteonecrosis of the jaws (BRONJ)-were set forth in the American Association of Oral and Maxillofacial S …
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ) - formerly referred …
Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
Cavalcante RC, Tomasetti G. Cavalcante RC, et al. J Craniomaxillofac Surg. 2020 Nov;48(11):1080-1086. doi: 10.1016/j.jcms.2020.09.008. Epub 2020 Sep 18. J Craniomaxillofac Surg. 2020. PMID: 32998853
PURPOSE: Medication-related osteonecrosis of the jaw (MRONJ) is a previously described debilitating condition in which patients experience progressive bone destruction in the maxilla and/or mandible after exposure to certain drugs. ...
PURPOSE: Medication-related osteonecrosis of the jaw (MRONJ) is a previously described debilitating condition in which patient …
Osteonecrosis of the jaw related to the use of bisphosphonates.
Van den Wyngaert T, Huizing MT, Vermorken JB. Van den Wyngaert T, et al. Curr Opin Oncol. 2007 Jul;19(4):315-22. doi: 10.1097/CCO.0b013e32819f820b. Curr Opin Oncol. 2007. PMID: 17545793 Review.
RECENT FINDINGS: Diagnostic criteria and a staging system for osteonecrosis of the jaw have been proposed, and histomorphologic analysis has confirmed osteonecrosis of the jaw as a proper disease, distinctively different from osteoradionecrosis. Variou …
RECENT FINDINGS: Diagnostic criteria and a staging system for osteonecrosis of the jaw have been proposed, and histomorphologi …
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, Tan W, Body JJ, Migliorati C, Lalla RV; MASCC Bone Study Group. Nicolatou-Galitis O, et al. Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23. Support Care Cancer. 2019. PMID: 30353228
INTRODUCTION: The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive properties (non-antiresorptives), such as antiangiogenics, tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, immune checkpoint …
INTRODUCTION: The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive proper …
Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW, Borromeo GL, Tsao C, Hardiman R, Hofman MS, Papatziamos Hjelle C, Siddique M, Cook GJR, Seymour JF, Ebeling PR. Sim IW, et al. J Clin Oncol. 2020 Sep 10;38(26):2971-2980. doi: 10.1200/JCO.19.02192. Epub 2020 Jul 2. J Clin Oncol. 2020. PMID: 32614699 Clinical Trial.
PURPOSE: Medication-related osteonecrosis of the jaw (MRONJ) is an infrequent but morbid and potentially serious condition associated with antiresorptive and antiangiogenic therapies. ...
PURPOSE: Medication-related osteonecrosis of the jaw (MRONJ) is an infrequent but morbid and potentially serious condition ass …
Exosomes from Adipose-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw by Inhibiting Macrophage M1 Polarization and Pyroptosis.
Zheng Y, Wang X, He Y, Chen S, He L, Zhang Y. Zheng Y, et al. Int J Nanomedicine. 2024 Nov 26;19:12675-12693. doi: 10.2147/IJN.S482849. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39619056 Free PMC article.
PURPOSE: Exosomes from mesenchymal stromal cells (MSCs) can prevent the development of medication-related osteonecrosis of the jaw (MRONJ) by promoting tooth socket wound healing; however, the exact mechanism remains to be clarified. ...
PURPOSE: Exosomes from mesenchymal stromal cells (MSCs) can prevent the development of medication-related osteonecrosis of the jaw …
Medication-Related Osteonecrosis of the Jaw.
Chen YF, Chang HP. Chen YF, et al. N Engl J Med. 2023 May 25;388(21):e69. doi: 10.1056/NEJMicm2209172. Epub 2023 May 20. N Engl J Med. 2023. PMID: 37212416 No abstract available.
Osteonecrosis of the jaw associated with pembrolizumab.
Pennings I, Moskowitz A, Shah G, Estilo C, Huryn JM, Yom SK. Pennings I, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Jul;136(1):e11-e14. doi: 10.1016/j.oooo.2022.12.013. Epub 2023 Jan 1. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023. PMID: 36804060 Free PMC article.
We report a case of osteonecrosis of the jaw (ONJ) with pembrolizumab, a rare yet possibly emerging complication. ...
We report a case of osteonecrosis of the jaw (ONJ) with pembrolizumab, a rare yet possibly emerging complication. ...
5,319 results